Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.

The Journal of comparative neurology | 2006

This is the first part of a two-part study to investigate the cellular distribution and temporal regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) subunits in the developing white matter and cortex in rat (part I) and human (part II). Western blot and immunocytochemistry were used to evaluate the differential expression of AMPAR subunits on glial and neuronal subtypes during the first 3 postnatal weeks in the Long Evans and Sprague Dawley rat strains. In Long Evans rats during the first postnatal week, GluR2-lacking AMPARs were expressed predominantly on white matter cells, including radial glia, premyelinating oligodendrocytes, and subplate neurons, whereas, during the second postnatal week, these AMPARs were highly expressed on cortical neurons, coincident with decreased expression on white matter cells. Immunocytochemical analysis revealed that cell-specific developmental changes in AMPAR expression occurred 2-3 days earlier by chronological age in Sprague Dawley rats compared with Long Evans rats, despite overall similar temporal sequencing. In both white and gray matter, the periods of high GluR2 deficiency correspond to those of regional susceptibility to hypoxic/ischemic injury in each of the two rat strains, supporting prior studies suggesting a critical role for Ca2+-permeable AMPARs in excitotoxic cellular injury and epileptogenesis. The developmental regulation of these receptor subunits strongly suggests that Ca2+ influx through GluR2-lacking AMPARs may play an important role in neuronal and glial development and injury in the immature brain. Moreover, as demonstrated in part II, there are striking similarities between rat and human in the regional and temporal maturational regulation of neuronal and glial AMPAR expression.

Pubmed ID: 16680782 RIS Download

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: NS31718
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS038475
  • Agency: NINDS NIH HHS, United States
    Id: R56 NS031718
  • Agency: NINDS NIH HHS, United States
    Id: NS38475
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD18655
  • Agency: NICHD NIH HHS, United States
    Id: HD01359
  • Agency: NICHD NIH HHS, United States
    Id: K08 HD001359
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD018655
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS031718

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Glial Fibrillary Acidic Protein (GFAP) (antibody)

RRID:AB_2109645

This polyclonal targets Glial Fibrillary Acidic Protein (GFAP)

View all literature mentions

Anti-Glutamate receptor 1 (antibody)

RRID:AB_2113602

This polyclonal targets Glutamate receptor 1

View all literature mentions

Anti-Glutamate Receptor 2 (antibody)

RRID:AB_2247874

This polyclonal targets Glutamate Receptor 2

View all literature mentions

Anti-Glutamate Decarboxylase, 65 kDa Isoform, clone GAD-6 (antibody)

RRID:AB_2263126

This monoclonal targets Glutamate Decarboxylase (GAD)

View all literature mentions

Anti-Glutamate Receptor 4 (antibody)

RRID:AB_90711

This polyclonal targets Glutamate Receptor 4

View all literature mentions